Latest Research

Treatment of Devic's Disease with Methotrexate and Prednisone

Alireza Minagar, MD;William A. Sheremata, MD

December 1st 2000

Yes, You Can!!! Go Beyond Physical Adversity and Live Life to Its Fullest

Robert M. Herndon, MD

December 1st 2000

Understanding Fluctuations of Multiple Sclerosis across the Menstrual Cycle

Maria K. Houtchens, MD;Ninel Gregori, BS;John W. Rose, MD

December 1st 2000

Editorial - Volume 2, Issue 3 - October 2000

Donald W. Paty, MD

October 1st 2000

Alternative Medicine and Multiple Sclerosis: An Objective Review from an American Perspective

Allen C. Bowling, MD, PhD;Ragaa Ibrahim, PhD;Thomas M. Stewart, JD, PA-C

October 1st 2000

What People with Newly Diagnosed MS (and their Families and Friends) Need to Know

Judy Wollin, RN, PhD;Helen Dale, MS;Nancy Spenser, PhD;Anne Walsh, RN

October 1st 2000

Swallowing and Speaking Challenges for the MS Patient

Shirley A. Brown, MA, CCC-SLP

October 1st 2000

Multiple Sclerosis and Pain: A Medical Focus

Marilyn Kassirer, MD

October 1st 2000

Impact of Multiple Sclerosis on Family and Employment: A Retrospective Study in the Aegean District of Turkey

Muhtesem Gedizlioglu, MD;Hatice Mavioglu, MD;Fatma Uzunel, Neurology Nurse;Pinar Ce, MD, PhD;Meral Oguz, PsyD;Ayse Sagduyu, MD;Behiye Özer, MD, PhD;Yasar Zorlu, MD, PhD;Egemen Idiman, MD;Hasan Korkmaz, MD

October 1st 2000

Multiple Sclerosis: Diagnosis, Medical Management, and Rehabilitation

Michael Kaufman, MD

October 1st 2000

Letter from the Editor - Volume 2, Issue 2 - June 2000

Robert M. Herndon, MD

Use of MRI Technology in Determining Prognosis and Tracking Therapeutic Benefit in Multiple Sclerosis

Timothy Vollmer, MD

A Fundamentally New View of Multiple Sclerosis

Richard Ransohoff, MD

Osteoporosis in Multiple Sclerosis: A Frequent, Serious, and Under-Recognized Problem

Robert M. Herndon, MD;Nirupa Mohandas, MD

Abstracts from the Annual Meeting of the Consortium of Multiple Sclerosis Centers

Wheelchair Selection and Configuration - Volume 2, Issue 2 - June 2000

Pauline Weldon, BN, RN

Hope in Multiple Sclerosis: A Nursing Perspective

Linda Morgante, RN, MSN, CRRN

Letter from the Editor - Volume 2, Issue 1 - March 2000

Robert M. Herndon, MD

The Evolution of Nursing Care in Multiple Sclerosis

J Halper, MSN, ANP, FAAN

Reduction of Relapses in Multiple Sclerosis after Anti-Alpha4 Integrin Antibody (Natalizumab)

A Minagar, MD;WA Sheremata, MD;TL Vollmer, MD;AJ Willmer-Hulme, PhD;M Koller, MD, MPH

Impact of a Comprehensive Long-Term Care Program on Caregivers and Persons with Multiple Sclerosis

EM Guagenti-Tax, DSW;TA DiLorenzo, PhD;L Tenteromano, RN;NG LaRocca, PhD;CR Smith, MD

Drug-Induced Dysphagia

KM Balzer, PharmD

Mobility in Multiple Sclerosis: More than just a Physical Problem

A Chan, BPT, MHSc;CS Heck, BSc, PT, MSc, PhD

Ishihara's Tests for Color Blindness: A useful Indicator of Visual Involvement in Multiple Sclerosis

MD Kaufman, MD;DM Lutz, ;J Norton, PhD

Multiple Sclerosis in Clinical Practice

Pauline Weldon, BN, RN

Letter from the Editor - Volume 1, Issue 2 - December 1999

Robert M. Herndon, MD

December 1st 1999

Adaptational Approach to Cognitive Rehabilitation in Multiple Sclerosis: Description of Three Models of Care

Päivi Hämäläinen, PhD;Arja Seinelä, MA;Juhani Ruutiainen, MD

December 1st 1999

Review of Common Management Strategies for Fatigue in Multiple Sclerosis

A Chan, BPT, MHSc

December 1st 1999

Results of an Ongoing, Open-Label, Safety-Extension Study of Interferon Beta-1a (Avonex) Treatment in Multiple Sclerosis

RM Herndon, MD;LD Jacobs, MD;ME Coats, MD;DE Goodkin, MD;MK Mass, MD;JR Richert, MD;RA Rudick, MD;EL Waubant, MD;B Weinstock-Guttman, MD;JO Scaramucci, MPH;BK Burnett, PhD;WE Jones, PhD;NA Simonian, MD

December 1st 1999

Rehabilitation in Multiple Sclerosis: Outcome Selection in Clinical Trials

JA Freeman, PhD, MSCP

December 1st 1999

...

28 29 30 31 32 33 >